B. Blak

First name

B.

Middle name

T.

Last name

Blak

Blak, B. T., Rigney, U., Sternhufvud, C., Davis, J., & Hammar, N. (2016). Weight change and healthcare resource use in English patients with type 2 diabetes mellitus initiating a new diabetes medication class. Int J Clin Pract. http://doi.org/10.1111/ijcp.12746

View

Rajaram, S., Wiecek, W., Lawson, R., Blak, B. T., Zhao, Y., Hackett, J., et al. (2017). Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach. PLoS One. http://doi.org/10.1371/journal.pone.0186739

View

Cavender, M. A., Norhammar, A., Birkeland, K. I., Jorgensen, M. E., Wilding, J. P., Khunti, K., et al. (2018). SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2018.01.085

View

J, P. H. W., Rigney, U., Blak, B. T., Nolan, S. T., Fenici, P., & Medina, J. (2019). Glycaemic, weight, and blood pressure changes associated with early versus later treatment intensification with dapagliflozin in United Kingdom primary care patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. http://doi.org/10.1016/j.diabres.2019.107791

View

Saine, M. E., Carbonari, D. M., Newcomb, C. W., Gallagher, A. M., Blak, B. T., Roy, J. A., et al. (2019). Concordance of hospitalizations between Clinical Practice Research Datalink and linked Hospital Episode Statistics among patients treated with oral antidiabetic therapies. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4853

View